Source:http://linkedlifedata.com/resource/pubmed/id/21087098
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2010-12-14
|
pubmed:abstractText |
Interleukin-18 binding protein (IL-18BP) is a soluble antagonist of IL-18 originally discovered while attempting to isolate a soluble receptor by using IL-18-ligand affinity column. IL-18BP has four isoforms (a, b, c, and d) in humans and two isoforms (c and d) in mice. The human isoforms IL-18BPa and IL-18BPc neutralize IL-18 activity sufficiently at an equimolar ratio; however IL-18BPb and IL-18BPd isoforms lack a complete Ig domain at C-terminus and lose the ability to neutralize IL-18 activity. Mouse IL-18BPc and IL-18BPd isoforms, possessing a similar complete Ig domain, also neutralize the biological activity of mouse IL-18 at an equimolar ratio. Here we expressed recombinant proteins of the active human IL-18BP isoforms and developed monoclonal antibodies (MAbs) against human IL-18BP a and c isoforms. We obtained two MAbs (78-4 and 38-3) of human IL-18BPa and two MAbs (18-7 and 29-6) of human IL-18BPc. The MAb clones 18-7 and 29-6 specifically recognized recombinant IL-18BPc in Western blot analyses and ELISA, whereas the MAb clone 78-4 recognized both isoforms in Western blot analyses, but only human IL-18BPa isoform in ELISA. We developed a sandwich ELISA by using the monoclonal antibody specific to human IL-18BPa isoform. The isoform-specific anti-human IL-18BP MAb may be a useful tool in categorizing a distinct group of patients from various autoimmune diseases related to IL-18BP.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Intercellular Signaling Peptides...,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Isoforms,
http://linkedlifedata.com/resource/pubmed/chemical/interleukin-18 binding protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1557-8348
|
pubmed:author |
pubmed-author:BaeSuyoungS,
pubmed-author:ChoiJidaJ,
pubmed-author:HANK SKS,
pubmed-author:HongJaewooJ,
pubmed-author:HongKwangwonK,
pubmed-author:JhunHyunjhungH,
pubmed-author:JoSeunghyunS,
pubmed-author:KimEunsomE,
pubmed-author:KimSoohyunS,
pubmed-author:KimSunjongS,
pubmed-author:LeeSiyoungS,
pubmed-author:RyooSoyoonS
|
pubmed:issnType |
Electronic
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
517-24
|
pubmed:meshHeading |
pubmed-meshheading:21087098-Animals,
pubmed-meshheading:21087098-Antibodies, Monoclonal,
pubmed-meshheading:21087098-Blotting, Western,
pubmed-meshheading:21087098-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:21087098-Female,
pubmed-meshheading:21087098-Humans,
pubmed-meshheading:21087098-Intercellular Signaling Peptides and Proteins,
pubmed-meshheading:21087098-Mice,
pubmed-meshheading:21087098-Mice, Inbred BALB C,
pubmed-meshheading:21087098-Protein Isoforms
|
pubmed:year |
2010
|
pubmed:articleTitle |
Development of isoform-specific monoclonal antibodies against human IL-18 binding protein.
|
pubmed:affiliation |
Department of Immunology, College of Medicine, Konkuk University, Chungju City, Chungbuk, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|